Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
Ter Veer E, van Rijssen LB, Besselink MG, Mali RMA, Berlin JD, Boeck S, Bonnetain F, Chau I, Conroy T, Van Cutsem E, Deplanque G, Friess H, Glimelius B, Goldstein D, Herrmann R, Labianca R, Van Laethem JL, Macarulla T, van der Meer JHM, Neoptolemos JP, Okusaka T, O'Reilly EM, Pelzer U, Philip PA, van der Poel MJ, Reni M, Scheithauer W, Siveke JT, Verslype C, Busch OR, Wilmink JW, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: verslype c. Lancet Oncol. 2018 Mar;19(3):e151-e160. doi: 10.1016/S1470-2045(18)30098-6. Lancet Oncol. 2018. PMID: 29508762 Free PMC article.
Systemic treatment of pancreatic cancer.
Van Cutsem E, Aerts R, Haustermans K, Topal B, Van Steenbergen W, Verslype C. Van Cutsem E, et al. Among authors: verslype c. Eur J Gastroenterol Hepatol. 2004 Mar;16(3):265-74. doi: 10.1097/00042737-200403000-00004. Eur J Gastroenterol Hepatol. 2004. PMID: 15195889 Review.
Lessons learned in the management of advanced pancreatic cancer.
Van Cutsem E, Verslype C, Grusenmeyer PA. Van Cutsem E, et al. Among authors: verslype c. J Clin Oncol. 2007 May 20;25(15):1949-52. doi: 10.1200/JCO.2006.09.4664. Epub 2007 Apr 23. J Clin Oncol. 2007. PMID: 17452675 No abstract available.
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
Tabernero J, Van Cutsem E, Díaz-Rubio E, Cervantes A, Humblet Y, André T, Van Laethem JL, Soulié P, Casado E, Verslype C, Valera JS, Tortora G, Ciardiello F, Kisker O, de Gramont A. Tabernero J, et al. Among authors: verslype c. J Clin Oncol. 2007 Nov 20;25(33):5225-32. doi: 10.1200/JCO.2007.13.2183. J Clin Oncol. 2007. PMID: 18024868 Clinical Trial.
A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.
Budiharto T, Haustermans K, Van Cutsem E, Van Steenbergen W, Topal B, Aerts R, Ectors N, Bielen D, Vanbeckevoort D, Goethals L, Verslype C. Budiharto T, et al. Among authors: verslype c. Radiat Oncol. 2008 Sep 22;3:30. doi: 10.1186/1748-717X-3-30. Radiat Oncol. 2008. PMID: 18808686 Free PMC article. Clinical Trial.
291 results